Establishment of a nomogram prediction model for severe primary lower limb lymphedema

Xingpeng Li, Yimeng Zhang, Mengke Liu, Jingru Wang, Jia Guo, Jie Ren, Wenbin Shen, Yunlong Yue, Rengui WangResearch Square 2024 · DOI

Abstract

Background: The International Society of Lymphology (ISL) guidelines have established grading criteria for primary lower limb lymphedema (PLEL), but there is a lack of a unified standard for assessing disease severity. Purpose: This study aimed to establish and validate a predictive model for evaluating severe PLEL. Methods and Materials: This retrospective study included 226 patients with unilateral PLEL (2018–2023), divided into non-severe (143) and severe (83) groups according to ISL criteria. Researchers recorded 26 MRI and 15 clinical features. Logistic regression, following feature selection via Lasso regularization, was used to construct a nomogram. Results: Six independent risk factors were identified: parallel line sign, crescent sign, longitudinal range, band sign thickness, fat area, and fat diameter. The model achieved a training set AUC of 0.908 and a validation set AUC of 0.891. Conclusions: The severity risk prediction model based on MRI and clinical practice has good discriminatory power and accuracy, providing a reference for individualized clinical prediction.

Introduction

Primary lower limb lymphedema (PLEL) is a chronic, debilitating condition resulting from congenital lymphatic malformations. Currently, the International Society of Lymphology (ISL) grades severity based on volume differences between affected and healthy limbs. However, volume measurement—via water displacement or manual circumference checks—is labor-intensive, prone to error, and fails to capture underlying structural changes. There is a critical need for a predictive model that integrates imaging and clinical data to accurately categorize disease severity and guide intervention.

Materials and Methods

This retrospective study analyzed 226 patients with unilateral PLEL. The cohort was categorized into "non-severe" (mild/moderate) and "severe" groups. A total of 41 features (26 MRI-based, 15 clinical) were extracted.

Feature selection was performed using one-way ANOVA followed by L1 regularization (Lasso), which effectively isolates the most significant predictors by penalizing less relevant variables. The final nomogram was built using logistic regression and validated through 5-fold cross-validation and Decision Curve Analysis (DCA) to assess clinical net benefit.

Results and Clinical Characteristics

The analysis identified six independent risk factors for severe PLEL. Notably, clinical symptoms like skin redness and poor elasticity were significantly more prevalent in the severe group.

Table 1: Comparison of clinical characteristics between non-severe and severe PLEL groups.

As shown in Table 1, 96.4% of severe patients exhibited involvement across the entire lower limb (longitudinal range), compared to 69.9% in the non-severe group. The model demonstrated high discriminative power, with a training AUC of 0.908 (95% CI: 0.868–0.947) and a validation AUC of 0.891 (95% CI: 0.847–0.935).

Discussion

The model highlights several key biological markers of disease progression. The inclusion of fat area and fat diameter as risk factors aligns with the understanding that lymphedema triggers adipose and fibrous tissue proliferation in the subcutaneous layer.

The "crescent sign" (subfascial effusion) was identified as a critical tipping point, suggesting that as fluid accumulates, it eventually breaches the superficial fascia into the subfascial space. Conversely, the "parallel line sign" (dilated subcutaneous lymphatic capillaries) was more common in non-severe cases, indicating it may be a hallmark of earlier-stage disease. The high prevalence of whole-limb involvement in severe cases suggests that advanced PLEL involves both peripheral and central lymphatic deficiencies.

Conclusion

The developed nomogram offers a robust, non-invasive tool for predicting PLEL severity. While limited by its retrospective nature and focus on primary lymphedema, the model provides a significant advancement for individualized clinical management. Future research should focus on multi-class models and validation in secondary lymphedema populations.

Summary updated

Abstract

<title>Abstract</title> Background The International Society of Lymphology (ISL) guidelines have established grading criteria for primary lower limb lymphedema (PLEL), but there is a lack of model on a unified standard for assessing the severity of the disease. Purpose The aim of this study was to establish and validate a predictive model for evaluating severe PLEL. Methods and Materials: This retrospective study included 226 patients with unilateral PLEL from 2018 to 2023, who were divided into non-severe (143 cases) and severe (83 cases) groups according to the ISL grading criteria. The two groups of patients had a total of 26 MRI and 15 clinical features recorded. One-way ANOVA was performed first, followed by multi-factor ANOVA, and logistic regression was used to construct a nomogram prediction model. The model’s performance was evaluated via the area under the receiver operating characteristic (ROC) curve (AUC), decision curve analysis, and internal validation. Results The predictive model identified six independent risk factors associated with the severity of PLEL, including the parallel line sign, crescent sign, longitudinal range, band sign thickness, fat area, and fat diameter. The nomogram model established based on the above six factors predicts a training set AUC of 0.908 (95% CI: 0.868–0.947) for severe PLEL, with a sensitivity of 0.868, specificity of 0.832, accuracy of 0.845, precision of 0.75. The AUC of the validation set was 0.891 (95% CI: 0.847 ~ 0.935), the sensitivity was 0.831, the specificity was 0.825, the accuracy was 0.827, the precision was 0.734. In decision curve analysis, more net benefit can be achieved when the threshold probability is between 1% and 90%. Conclusions The severity risk prediction model based on MRI and clinical practice has good discriminatory power and accuracy in evaluating the severity of PLEL which can provide a reference for individualized clinical prediction of PLEL.
BibTeX
@inproceedings{li2024establishment,
  author = {Xingpeng Li and Yimeng Zhang and Mengke Liu and Jingru Wang and Jia Guo and Jie Ren and Wenbin Shen and Yunlong Yue and Rengui Wang},
  title = {{Establishment of a nomogram prediction model for severe primary lower limb lymphedema}},
  booktitle = {Research Square},
  year = {2024},
  doi = {10.21203/rs.3.rs-4903908/v1},
}
Figure